Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-sparing of H1N1 vaccine via needle-free jet injector
NCT01582633Phase 3Unknown
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Jul 2012
- Primary completion
- Aug 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of 2012 trivalent influenza vaccine in influenza (4 arms), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Primary endpoints: Seroconversion Rate at 21 days, Seroprotection Rate at 21 days and 1 more. Status: unknown.
02
Drugs
2012 trivalent influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01582633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01582633.